The Journal of Allergy and Clinical Immunology has retracted a 2009 abstract, but don’t ask us why. The retraction notice for “Children with asthma and no URTI, more commonly have rhinovirus in their exhaled breath, than in mucous,” is another one we’ll file under “opaque“: Continue reading A mysterious retraction in the Journal of Allergy and Clinical Immunology
We’re continuing to follow the case of Jatinder Ahluwalia. As we reported on Tuesday, Ahluwalia was dismissed from graduate school at the University of Cambridge years before a University College London (UCL) investigation found had renumbered files to deceive a co-author, and had likely sabotaged his colleagues’ work while manipulating his solutions to improve how his results looked. The results of that investigation came to light as part of a Nature retraction.
Ahluwalia now works — and studies plagiarism, in fact — at the school of health and bioscience at the University of East London. We asked Neville Punchard, the school’s dean, whether the university was aware of Ahluwalia’s past. Punchard replied by email: Continue reading University of East London “looking into” Jatinder Ahluwalia’s career
Last week, we reported that the Scandinavian Journal of Immunology had noted that a 2002 paper by Silvia Bulfone-Paus and colleagues had been retracted, but hadn’t yet published the retraction notice. A commenter tipped us off this week that the notice is out: Continue reading Scandinavian Journal of Immunology publishes Bulfone-Paus retraction notice
That’s what we’ve uncovered so far after noticing the other day that the American Journal of the Medical Sciences (AJMS) had retracted a May 2010 article by a group of Israeli heart doctors led by Arthur Shiyovich, of Barzilai Medical Center in Ashkelon.
The paper described promising results in a study of a new test for diagnosing coronary artery disease at the bedside by measuring aspects of a patient’s pulse at the fingertip.
As AJMS editor David Ploth told us, the approach had seemed “kind of innovative” to him, so he’d accepted the manuscript: “It seemed like it might have some applicability.”
Ploth was therefore surprised sometime later to receive a letter from the authors requesting that the journal retract their paper. According to the journal: Continue reading Tangled leads: Cardiac study retraction reveals a company’s stopped trials, and lots of questions
Here at Retraction Watch, we’ve been following the case of Jatinder Ahluwalia with interest. You may recall that an investigation by University College London (UCL) found “beyond reasonable doubt” that Ahluwalia had renumbered files to deceive a co-author. UCL was also “highly confident” that Ahluwalia had messed with his solutions to make his results look better, and sabotaged his colleagues’ work. The report of that investigation was part of a Nature retraction notice.
We’ve now learned that UCL was not the first scene of misconduct by Ahluwalia. Yesterday, we obtained letters by University of Cambridge faculty and administrators describing repeated — and in the words of of one professor, amateurish — data fabrication by Ahluwalia that led to his dismissal from the university’s graduate program.
In a letter dated November 10, 1997, Martin Brand, then Ahluwalia’s PhD advisor, wrote: Continue reading Exclusive: Researcher found guilty of misconduct at UCL had been dismissed from Cambridge for data fabrication
The quote in the title of this post is a potential Onion headline that didn’t make it into print. It was part of an episode of This American Life that aired last week, and it seemed apropos, even though the subject here is superconductors rather than biology.
After all, we’ve written about a retraction that resulted from ordering the wrong mice. Today, we bring you the tale of a retraction caused by a mislabeled bottle. According to a retraction notice that appeared online last month in Physical Review B: Continue reading “Biologist realizes he’s been studying Cadbury egg”: Mislabeled bottle leads to Phys Rev B retraction
Unglaublich is the German word for unbelievable, and it’s an apt description for the latest development in the case of Joachim Boldt.
Boldt, a prominent German anesthesiologist, has been at the center of a research and publishing investigation since last October, when the journal Anesthesia & Analgesia retracted a 2009 article of his over concerns of data manipulation. This morning, the German medical board overseeing the case, the Landesärztekammer Rheinland-Pfalz (LÄK-RLP), released its findings — and they are truly stunning.
According to LAK, somewhere in the neighborhood of 90 of Boldt’s published articles might require retraction because the investigator failed to obtain approval from an institutional review board to conduct the research.
We don’t read German. But, fortunately, the LÄK-RLP announcement was accompanied by a joint letter posted to the websites of 11 major anesthesia journals. We do read English, and here’s what that letter says: Continue reading Unglaublich! Boldt investigation may lead to more than 90 retractions
The retraction notices for papers by Silvia Bulfone-Paus continue to appear. Yesterday, the Journal of Immunology posted notices for these three previously accepted retractions by the researcher, work at whose Borstel Centre lab is under investigation for misconduct.
- The IL-15 receptor alpha chain signals through association with Syk in human B cells (2001, cited 58 times, according to Thomson Scientific’s Web of Knowledge): Continue reading Three more Bulfone-Paus retraction notices out, in Journal of Immunology
Good people can make bad researchers, but can bad people make good science?
We’re agnostic on the question, but anyone who thinks the answer is no need look only as far as Edward Erin for validation of that view. An allergy expert in the U.K., Erin was convicted in 2009 of attempting to poison a mistress in an effort to induce an abortion.
serial adulterer who revelled in the sexual freedom of the ‘open relationship’ his wife allowed him.
Something was fishy at China Normal University. According to the journal Anti-Cancer Drugs, a 2010 paper by researchers at the Beijing school — “3,30′-Diindolylmethane negatively regulates Cdc25A and induces a G2/M arrest by modulation of microRNA21 in human breast cancer cells” — turned out to have suffered from an unfortunate anomaly. According to the retraction notice: Continue reading We wrote what? Breast cancer paper falls to rogue author